Trump had repeatedly stated the shots would be authorized before Election Day, despite government scientists signaling that timeline was unlikely. In the fall of 2020, the focus of both FDA and White House officials turned to the upcoming authorization of the first COVID-19 vaccines from Pfizer and Moderna.Īs previously reported, the White House objected to an FDA requirement that vaccine makers gather two months of safety data before filing their applications, contending that condition would delay the launch of the shots. Johnson also chaired a Senate committee hearing in November 2020 on treatment options and complained that doctors who prescribed hydroxychloroquine for COVID had been “scorned." Mike Lee of Utah and Ted Cruz of Texas wrote the FDA seeking an explanation for the denial to reinstate hydroxychloroquine’s authorization. But in mid-August, Johnson and fellow Republican Sens. There’s no indication such a request was made. Steve Scalise, the panel's top Republican, said the report was “further proof” that House Speaker Nancy Pelosi, D-Calif., “only set up this sham panel to carry out a political vendetta” against Trump. Jim Clyburn of South Carolina, said efforts to bend the FDA’s scientific work on treatments and vaccines exemplified how the “prior administration prioritized politics over public health.” But Louisiana Rep. “So that disagreement, which of course ultimately became somewhat public, was a source of pressure.” “We took a different stance at the FDA,” Hahn told investigators. Indeed, the FDA’s credibility largely stems from its reputation for scientific independence.īut Hahn told investigators that he felt pressure due to the “persistence” of Trump aide Peter Navarro's calls to reauthorize hydroxychloroquine after the FDA's decision to pull its emergency use.
READ NANCY DREW ONLINE FREE FREE
Frustrated by the pace of FDA's medical reviews, Trump repeatedly accused Hahn - without evidence - of delaying decisions on COVID-19 drugs and vaccines “for political reasons.”Īlthough FDA commissioners are politically appointed, the agency’s scientists are expected to conduct their reviews free from outside influence. Stephen Hahn, who was picked for the job by Trump in late 2019.
Much of the information comes from an interview with the agency's former commissioner, Dr. The report by the House subcommittee investigating the government's COVID-19 response focused on pressure at the FDA, which serves as gatekeeper for the drugs, vaccines and other countermeasures against the virus.
READ NANCY DREW ONLINE FREE INSTALL
But by June, FDA officials had concluded the drug was likely ineffective and could cause potentially dangerous heart complications, revoking its emergency use.Įfforts by the Trump administration to control the release of COVID-19 guidance and install political operatives at public health agencies have been well documented. At that time, many researchers hoped that existing antiviral drugs could be used to fight the virus. The FDA originally authorized use of hydroxychloroquine in late March 2020 based on small studies suggesting it could have some effectiveness against the coronavirus. Ingraham attended an Oval Office meeting with President Donald Trump, who himself took the anti-malaria drug.
READ NANCY DREW ONLINE FREE TV
Mehmet Oz, the celebrity heart surgeon who had a daytime TV show and is now the Republican Senate nominee in Pennsylvania. Investigators highlighted an email from Fox News’ Laura Ingraham and others from Dr. The report Wednesday by the Democratic-led House Select Subcommittee on the Coronavirus Crisis also sheds new light on the role that television personalities played in bringing hydroxychloroquine to the attention of top White House officials. health experts into reauthorizing a discredited COVID-19 treatment, according to a congressional investigation that provides new evidence of that administration’s efforts to override Food and Drug Administration decisions early in the pandemic. WASHINGTON - Officials in the Trump White House tried to pressure U.S.
0 kommentar(er)
